Quarterly report · Q2
4272.TEDINET S100PHL2
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥102.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥184.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥88.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥13.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥10.9bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥16.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.2bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.8bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥16.4bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.0bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥9.3bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥329.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥315.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥302.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥70.3bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥69.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥259.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥246.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥233.5bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥41.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥38.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥52.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥50.4bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥47.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥9.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥6.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥11.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥67.04 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.63 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.7 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.27 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.35 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥67.02 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.65 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥54.26 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 78.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥4.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥55m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥899m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥137m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥137m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥3.7bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥46.1bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥46.0bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥7.8bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥26.7bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥26.7bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.0bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥98.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥98.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥16.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥102.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥102.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥137m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥51m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥919m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥123m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥123m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥3.4bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥37.7bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥37.6bn |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥71m |
| jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥25.5bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥25.5bn |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Medicinereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E00836-000Safety Systemsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥3.2bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥84.8bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥84.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥71m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥89.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥88.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥123m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥14.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 583
| Item | Context | Value | Unit |
|---|---|---|---|
| Decrease increase in inventories ope cf | CurrentYTDDuration | -8441000000 | JPY |
| Decrease increase in prepaid expenses ope cf | Prior1YTDDuration | -233000000 | JPY |
| Decrease increase in prepaid expenses ope cf | CurrentYTDDuration | -602000000 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YTDDuration | 1323000000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | -593000000 | JPY |
| Decrease increase in advance payments ope cf | Prior1YTDDuration | 14000000 | JPY |
| Decrease increase in advance payments ope cf | CurrentYTDDuration | -12000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 1431000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 3315000000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -670000000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -387000000 | JPY |
| Increase decrease in accrued expenses ope cf | Prior1YTDDuration | -2000000 | JPY |
| Increase decrease in accrued expenses ope cf | CurrentYTDDuration | -348000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 15000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 17000000 | JPY |
| Increase decrease in net defined benefit asset ope cf | Prior1YTDDuration | -164000000 | JPY |
| Increase decrease in net defined benefit asset ope cf | CurrentYTDDuration | -337000000 | JPY |
| Other net ope cf | Prior1YTDDuration | -239000000 | JPY |
| Other net ope cf | CurrentYTDDuration | -851000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 15714000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 14934000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 737000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 935000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -41000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -38000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -2096000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -3853000000 | JPY |
| Income taxes refund ope cf | Prior1YTDDuration | 70000000 | JPY |
| Income taxes refund ope cf | CurrentYTDDuration | 56000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 14384000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 12035000000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -19000000 | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | -339000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1YTDDuration | 41000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYTDDuration | 20000000 | JPY |
| Payments of short term loans receivable inv cf | Prior1YTDDuration | － | JPY |
| Payments of short term loans receivable inv cf | CurrentYTDDuration | -66000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -3672000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -5989000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 1490000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 32000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -167000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -151000000 | JPY |
| Purchase of short term investment securities inv cf | Prior1YTDDuration | － | JPY |
| Purchase of short term investment securities inv cf | CurrentYTDDuration | -402000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -49000000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -2099000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 112000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 15000000 | JPY |
| Proceeds from redemption of investment securities inv cf | Prior1YTDDuration | 119000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |